The presence of EVs carrying EAAT2 protein (EV-EAAT2) on their surface was assessed in plasma samples of 110 MS patients (42 RRMS patients in relapse, 41 RRMS patients in remission, 27 SPMS patients) and 23 healthy controls. Here, SLC1A2 is linked to myeloid sarcoma.